Nusunland Awarded '2021 Leading Enterprise in Healthcare' by Wabei; Revenue Grew 39% as a BSE Innovative Biopharma

This article is sourced from: Digbei.com

Wabei News, April 2nd: In the award list released by Wabei News during the "6th Wabei Beijing Stock Exchange · New Third Board Leading Enterprise Annual Conference," the Beijing Stock Exchange's innovative pharmaceutical company Northland (430047) was awarded the "2021 Medical and Health Leading Enterprise" award.

Northland Honored with Digibei "2021 Medical Health Leading Enterprise" Award

Data from the Waibei Research Institute shows that Northland is an innovative biopharmaceutical company specializing in the research, production, and sales of gene therapy drugs, recombinant protein drugs, and ophthalmic medications. In 2021, the company achieved revenue of 57.75 million yuan, a year-on-year increase of 39.36%.

According to reports, the Northland fundraising project "Phase IIa Clinical Trial of Recombinant Human Thymosin β4 for Injection (Project Code: NL005) for the Treatment of Ischemia-Reperfusion Injury in Acute Myocardial Infarction" has achieved phased results. As of the end of January, enrollment, follow-up, and data statistical analysis have been completed, achieving the preliminary objectives of exploring dosing safety, effective dose range, and evaluation criteria selection. Active preparations are underway for the subsequent Phase IIb clinical trial.

The "6th Annual Meeting of Wabei Beijing Stock Exchange·New Third Board Leading Enterprises" officially kicked off on November 8, 2021, receiving active responses from listed companies on the Beijing Stock Exchange, companies listed on the New Third Board, and intermediary agencies. A total of 103 companies participated in the event, including 22 companies listed on the Beijing Stock Exchange, with 51 company chairmen participating in the "Beijing Stock Exchange·New Third Board Outstanding Chairman" selection. During the two-week voting period, the total number of votes reached 3.45 million.

In order to ensure the fairness, impartiality, and transparency of the selection, the Waibe.com invited experts in the NEEQ field, securities companies, accounting firms, investment institutions, and authoritative media to form a jury to review the shortlisted list from December 1 to December 10, 2021. The finalists were evaluated based on the online voting results of this year-end selection activity and the comprehensive situation of the chairman/enterprise, and the final list of winners was determined.